In a recent study, Lee and colleagues [35] evaluated the clinical significant of TH mRNA transcripts levels in the peripheral blood of patients with neuroblastoma demonstrating that TH expression was associated with high-risk features, advanced stage and worse outcome. This evidence concerns the gene TH and neuroblastoma.